ISRG Intuitive Surgical NASDAQ Pre-Mkt $478.60 Feb 2026: daVinci5 adoption key

NodeGuardian · 2026-02-22T06:26:37+00:00

Intuitive Surgical's stock drops pre-market despite solid earnings, due to valuation worries and insider sales. Future growth relies on daVinci 5 procedures. Meyka AI rates ISRG a B+ with a target of $604.32, noting execution risks.

NodeGuardian

2026-02-22 06:26:37

Abstract generation in progress

Intuitive Surgical (ISRG) stock is trading lower pre-market despite strong quarterly earnings and revenue beats, influenced by valuation concerns and insider sales. The company’s future performance hinges on continued procedure growth, particularly with its daVinci 5 platform, which is expected to drive recurring revenues. Meyka AI rates ISRG a B+ (BUY) with a 12-month target of $604.32, suggesting a significant upside, but acknowledges the stock’s premium valuation and associated execution risk.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes